[][com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=79776]], camposKey:0165-5701 2023-11-01 Randomised placebo-controlled clinical trial evaluating the impact of a new visual rehabilitation program on neuroadaptation in patients implanted with trifocal intraocular lenses40354053, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=80393]], camposKey:2168-6149 2023-08-14 Safety and Efficacy of ApTOLL in Patients with Ischemic Stroke Undergoing Endovascular Treatment: A Phase 1/2 Randomized Clinical Trial779788, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=80394]], camposKey:1591-0199 2023-08-01 Neutrophil¿Lymphocyte ratio is associated with poor clinical outcome after mechanical thrombectomy in stroke in patients with COVID-19386392, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=80395]], camposKey:2077-0383 2023-07-01 Investigating the Prognostic Role of Peripheral Inflammatory Markers in Mild Cognitive Impairment00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=80396]], camposKey:0033-8419 2023-04-01 Thrombectomy versus Medical Management for Isolated Anterior Cerebral Artery Stroke: An International Multicenter Registry Study00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=75471]], camposKey:1051-2284 2023-03-01 Intracranial atherosclerotic plaque enhancement and long-term risk of future strokes: A prospective, longitudinal study289301, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=75472]], camposKey:2168-6149 2023-02-13 Association of Endovascular Thrombectomy vs Medical Management with Functional and Safety Outcomes in Patients Treated beyond 24 Hours of Last Known Well: The SELECT Late Study172182, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=75408]], camposKey:1661-7827 2023-02-01 Randomized Controlled Trial Evaluating the Benefit of a Novel Clinical Decision Support System for the Management of COVID-19 Patients in Home Quarantine: A Study Protocol00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=75409]], camposKey:2222-3959 2023-01-18 Visual perception alterations in COVID-19: a preliminary study19, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=80398]], camposKey:1663-4365 2023-01-01 Association of candidate genetic variants and circulating levels of ApoE/ApoJ with common neuroimaging features of cerebral amyloid angiopathy00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=80397]], camposKey:1747-4930 2023-01-01 Penumbral Rescue by normobaric O = O administration in patients with ischemic stroke and target mismatch proFile (PROOF): Study protocol of a phase IIb trial00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=80399]], camposKey:0028-4793 2023-01-01 Trial of Endovascular Thrombectomy for Large Ischemic Strokes.12591271, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=69370]], camposKey:1471-2415 2022-12-01 Study protocol for a randomized controlled trial of the NEIVATECH virtual reality system to improve visual function in children with anisometropic amblyopia00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=75473]], camposKey:1474-4422 2022-10-01 Clinical characterisation of patients in the post-acute stage of anti-NMDA receptor encephalitis: a prospective cohort study and comparison with patients with schizophrenia spectrum disorders899910, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=75474]], camposKey:1664-2295 2022-09-27 Editorial: Understanding stroke recovery to improve outcomes: From acute care to chronic rehabilitation00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=69372]], camposKey:2396-9873 2022-09-01 European Stroke Organisation guidelines on treatment of patients with intracranial atherosclerotic disease34, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=69371]], camposKey:0364-5134 2022-09-01 Thrombectomy versus Medical Management in Mild Strokes due to Large Vessel Occlusion: Exploratory Analysis from the EXTEND-IA Trials and a Pooled International Cohort364378, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=69373]], camposKey:2297-055X 2022-07-08 A Polygenic Risk Score Based on a Cardioembolic Stroke Multitrait Analysis Improves a Clinical Prediction Model for This Stroke Subtype00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=69374]], camposKey:2297-055X 2022-07-04 Blood-Based Biomarkers to Search for Atrial Fibrillation in High-Risk Asymptomatic Individuals and Cryptogenic Stroke Patients00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=69375]], camposKey:0006-8950 2022-07-01 Multi-Ancestry GWAS reveals excitotoxicity associated with outcome after ischaemic stroke23942406, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=69376]], camposKey:0148-396X 2022-06-01 Characteristics of a COVID-19 Cohort With Large Vessel Occlusion: A Multicenter International Study725733, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=68297]], camposKey:2352-9067 2022-04-01 Proteins and pathways in atrial fibrillation and atrial cardiomyopathy underlying cryptogenic stroke00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=66666]], camposKey:0213-4853 2022-01-01 Dyslipidemias and stroke prevention: recommendations of the Study Group of Cerebrovascular Diseases of the Spanish Society of Neurology Dislipidemias y prevención del ictus: recomendaciones del Grupo de Estudio de Enfermedades Cerebrovasculares de la Sociedad Española de Neurología6172, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=69378]], camposKey:0910-8327 2022-01-01 Intensive 90-day textile wearable Holter monitoring: an alternative to detect paroxysmal atrial fibrillation in selected patients with cryptogenic stroke00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=69377]], camposKey:1351-5101 2022-01-01 International controlled study of revascularization and outcomes following COVID-positive mechanical thrombectomy00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=69379]], camposKey:2059-8688 2021-12-01 Decline in subarachnoid haemorrhage volumes associated with the first wave of the COVID-19 pandemic542552, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=66667]], camposKey:0039-2499 2021-12-01 Infarct core growth velocity: Characterizing the hot penumbra without looking at it40074009, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=69380]], camposKey:1471-2377 2021-12-01 Stroke etiologies in patients with COVID-19: the SVIN COVID-19 multinational registry00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=66668]], camposKey:1868-4483 2021-10-01 Predicting Atrial Fibrillation with High Risk of Embolization with Atrial Strain and NT-proBNP735741, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=66670]], camposKey:0006-8950 2021-08-01 Single nucleotide variations in ZBTB46 are associated with post-thrombolytic parenchymal haematoma24162426, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=66671]], camposKey:1747-4930 2021-07-01 Global impact of COVID-19 on stroke care573584, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=66839]], camposKey:0028-3878 2021-06-08 Global Impact of COVID-19 on Stroke Care and IV Thrombolysis00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=66674]], camposKey:1747-4930 2021-06-01 Cerebrovascular events and outcomes in hospitalized patients with COVID-19: The SVIN COVID-19 Multinational Registry437447, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=69382]], camposKey:1759-8478 2021-06-01 SELECTion criteria for large core trials: Dogma or data?500504, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=66673]], camposKey:0303-8467 2021-06-01 Smart glasses evaluation during the COVID-19 pandemic: First-use on Neurointerventional procedures00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=66676]], camposKey:1015-9770 2021-05-01 Impact of Mediterranean Diet prior to Stroke on the Prognosis of Patients Undergoing Endovascular Treatment303309, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=69383]], camposKey:2162-3279 2021-04-01 Neurological symptoms in Covid-19 patients in the emergency department00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=69384]], camposKey:2077-0383 2021-03-01 Circulating AQP4 levels in patients with cerebral amyloid angiopathy-associated intracerebral hemorrhage115, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=66677]], camposKey:1351-5101 2021-02-01 B-type natriuretic peptide over N-terminal pro-brain natriuretic peptide to predict incident atrial fibrillation after cryptogenic stroke540547, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=69385]], camposKey:2164-2591 2021-02-01 Multitasking compensatory saccadic training program for hemianopia patients: A new approach with 3-dimensional real-world objects119, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=69386]], camposKey:2227-9059 2021-01-01 Comparison of plasma lipoprotein composition and function in cerebral amyloid angiopathy and alzheimer¿s disease114, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=66679]], camposKey:0039-2499 2021-01-01 Delayed Neurological Improvement after Full Endovascular Reperfusion in Acute Anterior Circulation Ischemic Stroke22102217, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=64747]], camposKey:0210-0010 2021-01-01 Efecto del tratamiento con benzodiacepinas en el pronóstico hospitalario de la enfermedad por coronavirus 2019201209, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=65165]], camposKey:1177-5467 2021-01-01 Oct variability prevents their use as robust biomarkers in multiple sclerosis20252036, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=68442]], camposKey:2076-3425 2021-01-01 Preliminary evaluation of the clinical benefit of a novel visual rehabilitation program in patients implanted with trifocal diffractive intraocular lenses: A blinded randomized placebo¿controlled clinical trial11810, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=64746]], camposKey:0213-4853 2021-01-01 Prevención de ictus en pacientes con diabetes mellitus tipo 2 o prediabetes. Recomendaciones del Grupo de Estudio de Enfermedades Cerebrovasculares de la Sociedad Española de Neurología00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=64748]], camposKey:0213-4853 2021-01-01 Recomendaciones de la Sociedad Española de Neurología para la prevención del ictus. Actuación sobre los hábitos de vida y la contaminación atmosférica00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=64559]], camposKey:0210-0010 2021-01-01 Rehabilitación integral postictus: efectos a largo plazo y factores socioambientales condicionantes del acceso19, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=69381]], camposKey:2077-0383 2021-01-01 Rp11-362k2.2:Rp11-767i20.1 genetic variation is associated with post-reperfusion therapy parenchymal hematoma. a gwas meta-analysis00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=66681]], camposKey:1591-0199 2021-01-01 Safety and feasibility of transradial use of 8F balloon guide catheter Flowgate2 for endovascular thrombectomy in acute ischemic stroke00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=66680]], camposKey:0039-2499 2021-01-01 SARS-CoV-2 and Stroke Characteristics: A Report from the Multinational COVID-19 Stroke Study Group00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=66682]], camposKey:1079-5006 2021-01-01 Sex-specific protective effects of APOE ¿2 on cognitive performance4149, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=66678]], camposKey:1759-8478 2021-01-01 Thrombectomy for secondary distal, medium vessel occlusions of the posterior circulation: Seeking complete reperfusion00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=65727]], camposKey:0022-510X 2020-12-15 Anosmia is associated with lower in-hospital mortality in COVID-1900, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=69388]], camposKey:2045-2322 2020-12-01 Genome-Wide Association Study of VKORC1 and CYP2C9 on acenocoumarol dose, stroke recurrence and intracranial haemorrhage in Spain00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=69387]], camposKey:2045-2322 2020-12-01 Quantified ischemic core¿s radiological hypodensity and risk of parenchymal hematoma in > 4.5 h-window stroke thrombectomy00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=77492]], camposKey:2524-3489 2020-12-01 Safety and efficacy of intravenous thrombolysis in stroke patients on prior antiplatelet therapy in the WAKE-UP trial00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=69389]], camposKey:1664-2295 2020-11-26 Oral Anticoagulation and Risk of Symptomatic Hemorrhagic Transformation in Stroke Patients Treated With Mechanical Thrombectomy: Data From the Nordictus Registry00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=69390]], camposKey:0140-6736 2020-11-14 Intravenous alteplase for stroke with unknown time of onset guided by advanced imaging: systematic review and meta-analysis of individual patient data15741584, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=66683]], camposKey:0021-9150 2020-11-01 The Barcelona-Asymptomatic Intracranial Atherosclerosis (AsIA) study: Subclinical cervico-cerebral stenosis and middle cerebral artery pulsatility index as predictors of long-term incident cognitive impairment104109, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=66684]], camposKey:1747-4930 2020-10-01 Impact of COVID-19 outbreak on ischemic stroke admissions and in-hospital mortality in North-West Spain755762, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=65733]], camposKey:0017-8748 2020-09-01 Frequency and Type of Red Flags in Patients With Covid-19 and Headache: A Series of 104 Hospitalized Patients16641672, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=66685]], camposKey:1351-5101 2020-08-01 Large vessel occlusion is independently associated with atrial fibrillation detection16181624, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=65735]], camposKey:1129-2369 2020-07-29 Factors associated with the presence of headache in hospitalized COVID-19 patients and impact on prognosis: A retrospective cohort study00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=66686]], camposKey:0213-4853 2020-05-01 Will neurological care change over the next 5 years due to the COVID-19 pandemic? Key informant consensus survey ¿Va a cambiar la neurología tras la pandemia de COVID-19 en los próximos 5 años? Estudio de enfoque mediante informadores clave252257, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=66687]], camposKey:0340-5354 2020-03-01 Comment on the article ¿Symptomatic carotid near-occlusion causes a high risk of recurrent ipsilateral ischemic stroke¿ by Gu et al.849851, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=58205]], camposKey:0039-2499 2020-01-01 Brain Atrophy and the Risk of Futile Endovascular Reperfusion in Acute Ischemic Stroke15141521, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=66688]], camposKey:0039-2499 2020-01-01 Early Neurological Change after Ischemic Stroke Is Associated with 90-Day Outcome132141, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=66690]], camposKey:1351-5101 2020-01-01 Impact of COVID-19 outbreak in reperfusion therapies of acute ischaemic stroke in northwest Spain00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=61691]], camposKey:1664-2295 2020-01-01 Neurological Comorbidity Is a Predictor of Death in Covid-19 Disease: A Cohort Study on 576 Patients00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=66689]], camposKey:0213-4853 2020-01-01 Proprotein convertase subtilisin/kexin type 9 inhibitors in secondary prevention of vascular events in patients with stroke: Consensus document and practice guidance Inhibidores de la proproteína convertasa subtilisina/kexina tipo 9 (iPCSK9) en la prevención secundaria de episodios vasculares en pacientes con ictus isquémico: Documento de consenso y aplicaciones prácticas00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=68441]], camposKey:2077-0383 2020-01-01 Stimuli characteristics and psychophysical requirements for visual training in amblyopia: A narrative review39850, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=59778]], camposKey:2090-004X 2020-01-01 The Potential of Virtual Reality for Inducing Neuroplasticity in Children with Amblyopia00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=66691]], camposKey:2287-6391 2020-01-01 The value of transcranial doppler sonography in hyperperfusion syndrome after carotid artery stenting: A nationwide prospective study254257, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=66692]], camposKey:1387-2877 2020-01-01 Third Ventricle Width Assessed by Transcranial Sonography as Predictor of Long-Term Cognitive Impairment741749, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=52803]], camposKey:1743-0003 2020-01-01 Visual processing speed in hemianopia patients secondary to acquired brain injury: a new assessment methodology00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=69306]], camposKey:0039-2499 2019-08-01 Sphenopalatine Ganglion Stimulation to Augment Cerebral Blood Flow: A Randomized, Sham-Controlled Trial21082117, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=43062]], camposKey:0140-6736 2019-07-20 An injectable implant to stimulate the sphenopalatine ganglion for treatment of acute ischaemic stroke up to 24 h from onset (ImpACT-24B): an international, randomised, double-blind, sham-controlled, pivotal trial219229, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=41778]], camposKey:0140-6736 2019-07-13 Extending thrombolysis to 4·5¿9 h and wake-up stroke using perfusion imaging: a systematic review and meta-analysis of individual patient data139147, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=41780]], camposKey:1015-9770 2019-07-01 Age- and sex-specific risk profiles and in-hospital mortality in 13,932 Spanish stroke patients151164, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=41779]], camposKey:1015-9770 2019-07-01 Relevance of collaterals for the success of neuroprotective therapies in acute ischemic stroke: Insights from the randomized URICO-ICTUS Trial171177, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=69307]], camposKey:2168-6149 2019-06-01 Functional Outcome of Intravenous Thrombolysis in Patients With Lacunar Infarcts in the WAKE-UP Trial641649, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=41781]], camposKey:1936-8798 2019-05-13 Clinical Predictors of Hyperperfusion Syndrome Following Carotid Stenting: Results From a National Prospective Multicenter Study873882, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=43063]], camposKey:1868-4483 2019-04-15 The Neuronal Ischemic Tolerance Is Conditioned by the Tp53 Arg72Pro Polymorphism204215, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=43064]], camposKey:0021-9150 2019-03-01 The Barcelona-Asymptomatic Intracranial Atherosclerosis study: Subclinical intracranial atherosclerosis as predictor of long-term vascular events132136, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=43553]], camposKey:2072-6643 2019-01-01 Influence of hyperglycemia associated with enteral nutrition on mortality in patients with stroke00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=41782]], camposKey:1747-4930 2019-01-01 Intracranial arterial wall imaging: Techniques, clinical applicability, and future perspectives00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=43065]], camposKey:1474-4422 2019-01-01 Penumbral imaging and functional outcome in patients with anterior circulation ischaemic stroke treated with endovascular thrombectomy versus medical therapy: a meta-analysis of individual patient-level data4655, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=43445]], camposKey:0028-3878 2019-01-01 Validation of a clinical-genetics score to predict hemorrhagic transformations after rtPA851863, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=43066]], camposKey:1474-4422 2018-12-01 Rivaroxaban or aspirin for patent foramen ovale and embolic stroke of undetermined source: a prespecified subgroup analysis from the NAVIGATE ESUS trial10531060, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=43067]], camposKey:0014-2565 2018-10-01 Factors associated with poor anticoagulation control with vitamin K antagonists among outpatients attended in Internal Medicine and Neurology. The ALADIN study Factores asociados al mal control de la anticoagulación con antivitamina K en pacientes con fibrilación auricular no valvular atendidos en consultas de Medicina Interna y Neurología. Estudio ALADIN327335, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=41784]], camposKey:1474-4422 2018-10-01 Imaging features and safety and efficacy of endovascular stroke treatment: a meta-analysis of individual patient-level data895904, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=41783]], camposKey:0271-678X 2018-10-01 Relative cerebral blood volume is associated with collateral status and infarct growth in stroke patients in SWIFT PRIME18391847, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=70952]], camposKey:0271-678X 2018-10-01 Relative cerebral blood volume is associated with collateral status and infarct growth in stroke patients in SWIFT PRIME (vol 38, pg 1839, 2018)18491849, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=43068]], camposKey:2287-6391 2018-05-01 Intracranial large artery disease of non-atherosclerotic origin: Recent progress and clinical implications208217, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=41785]], camposKey:0899-9007 2018-04-01 Influence of a multidisciplinary protocol on nutritional status at diagnosis in amyotrophic lateral sclerosis6772, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=43069]], camposKey:0167-5273 2018-01-15 Yield of atrial fibrillation detection with Textile Wearable Holter from the acute phase of stroke: Pilot study of Crypto-AF registry4550, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=69310]], camposKey:0039-2499 2018-01-01 Atrial Dysfunction Markers Predicted AF in Elderly Cryptogenic Stroke Patients00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=41786]], camposKey:1474-4422 2018-01-01 Effect of general anaesthesia on functional outcome in patients with anterior circulation ischaemic stroke having endovascular thrombectomy versus standard care: a meta-analysis of individual patient data4753, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=43907]], camposKey:0213-4853 2018-01-01 Use of cardiovascular polypills for the secondary prevention of cerebrovascular disease Uso de la polipíldora cardiovascular en la prevención secundaria de la enfermedad cerebrovascular00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=41787]], camposKey:0210-0010 2017-10-16 Clinical profile and satisfaction with anticoagulated treatment in patients with non-valvular atrial fibrillation attended in internal medicine and neurology departments of Spain Perfil clínico y satisfacción con el tratamiento anticoagulante en pacientes con fibrilación auricular no valvular atendidos en consultas de medicina interna y neurología de España361367, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=69309]], camposKey:0195-668X 2017-08-01 Rapid atrial rate and implantable loop recorders for embolic strokes of unknown source: report of more than 2-years follow up in a single centre165165, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=41788]], camposKey:0039-2499 2017-05-01 GRECOS Project (Genotyping Recurrence Risk of Stroke): The Use of Genetics to Predict the Vascular Recurrence after Stroke11471153, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=41789]], camposKey:1474-4422 2017-05-01 Safety and efficacy of thrombectomy in acute ischaemic stroke (REVASCAT): 1-year follow-up of a randomised open-label trial369376, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=41790]], camposKey:1052-3057 2017-02-01 Reported Prestroke Physical Activity Is Associated with Vascular Endothelial Growth Factor Expression and Good Outcomes after Stroke425430, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=41793]], camposKey:1747-4930 2017-01-01 Collaterals 2016: Translating the collaterome around the globe338342, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=44183]], camposKey:0213-4853 2017-01-01 Criterios para la formación y capacitación en Neurorradiología Intervencionista-Neurointervencionismo, acordados por el Grupo Español de Neurorradiología Intervencionista (GENI), la Sociedad Española de Neurorradiología (SENR), el Grupo de Estudio de Enfermedades Cerebrovasculares (GEECV) de la Sociedad Española de Neurología (SEN) y el grupo experto en enfermedades vasculares de la Sociedad...00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=41791]], camposKey:0022-3050 2017-01-01 Principles of precision medicine in stroke5461, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=41792]], camposKey:1747-4930 2017-01-01 Uric acid therapy improves the outcomes of stroke patients treated with intravenous tissue plasminogen activator and mechanical thrombectomy377382, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=41794]], camposKey:0213-4853 2016-11-01 Atypical presentation of a distal cerebral aneurysm: Location and outcome in a young woman Aneurisma intracraneal distal con presentación atípica, localización y evolución en una mujer joven641642, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=41795]], camposKey:0033-8419 2016-06-01 Analysis of workflow and time to treatment and the effects on outcome in endovascular treatment of acute ischemic stroke: Results from the SWIFT PRIME randomized controlled trial888897, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=69311]], camposKey:0039-2499 2016-02-01 Collateral Blood Flow and Inflammatory Markers in Intracranial Atherosclerosis: Angiography and Biomarker Correlates in the BIOSIS and SAMMPRIS Trials00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=43070]], camposKey:1660-4431 2016-01-01 Biomarkers, Natural Course and Prognosis93108, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=41796]], camposKey:1052-3057 2015-11-01 Metabolic Syndrome Predicts Refractoriness to Intravenous Thrombolysis in Acute Ischemic Stroke26052612, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=69321]], camposKey:1352-4585 2015-09-01 Netrin-1: a new player in multiple sclerosis pathogenesis?734735, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=69323]], camposKey:1747-4930 2015-04-01 Accuracy of transcranial duplex sonography, compared with CT angiography, for detection of intracranial arterial occlusions in acute stroke344344, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=69325]], camposKey:1747-4930 2015-04-01 Cerebral infarct core estimation using aspects on plain CT and perfusion CT: Interregional variability307307, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=69324]], camposKey:1747-4930 2015-04-01 Temporal evolution of symptomatic intracranial atherosclerotic plaque post-contrast enhancement: A serial high-resolution MRI study319319, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=69327]], camposKey:0039-2499 2015-02-01 Coexisting Cerebrovascular Disease and Risk of Occult Atrial Fibrillation in Patients With Embolic Stroke of Undetermined Source00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=69326]], camposKey:0039-2499 2015-02-01 Outcome of Cervical Internal Carotid Artery Occlusions After Intravenous Thrombolysis in Acute Ischemic Stroke Patients With Tandem Occlusions00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=41797]], camposKey:1591-0199 2015-02-01 Severe cerebral vasospasm in chronic cocaine users during neurointerventional procedures: A report of two cases1922, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=41798]], camposKey:0165-5728 2015-01-01 Improvement of fatigue in multiple sclerosis by physical exercise is associated to modulation of systemic interferon response811, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=43298]], camposKey:0213-4853 2014-07-05 Clinical management guidelines for subarachnoid haemorrhage. Diagnosis and treatment Guía de actuación clínica en la hemorragia subaracnoidea. Sistemática diagnóstica y tratamiento353370, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=41799]], camposKey:0197-4580 2014-05-01 Thalamic diffusion differences related to cognitive function in white matter lesions11031110, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=41802]], camposKey:0021-9150 2014-03-01 Ankle-brachial index in screening for asymptomatic carotid and intracranial atherosclerosis7275, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=41803]], camposKey:0213-4853 2014-03-01 Guidelines for the treatment of acute ischaemic stroke Guía para el tratamiento del infarto cerebral agudo102122, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=41800]], camposKey:0001-6314 2014-03-01 Intravenous thrombolysis in ischemic stroke with unknown onset using CT perfusion178183, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=41801]], camposKey:0021-9150 2014-03-01 Predictive value of ankle-brachial index and PAI-1 in symptomatic intracranial atherosclerotic disease recurrence186189, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=41804]], camposKey:0210-0010 2014-02-21 Spontaneous resolution of dural arteriovenous fistula type IV Resolución espontánea de una fístula dural arteriovenosa tipo IV190191, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=41814]], camposKey:0213-4853 2014-01-01 Analysis of stroke care resources in Spain in 2012: Have we benefitted from the Spanish Health System's stroke care strategy? Análisis de recursos asistenciales para el ictus en España en 2012: ¿beneficios de la Estrategia del Ictus del Sistema Nacional de Salud?387396, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=69312]], camposKey:1015-9770 2014-01-01 Diffusion tensor imaging, intracranial vascular resistance and cognition in middle-aged asymptomatic subjects497497, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=41806]], camposKey:0210-0010 2014-01-01 Endovascular treatment of critical basilar stenosis with a solitaire ® stent device: A first experience in our centre Tratamiento endovascular de una estenosis crítica basilar con dispositivo stent solitaire ®: Primera experiencia en nuestro centro118120, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=41815]], camposKey:0213-4853 2014-01-01 Guidelines for the preventive treatment of ischaemic stroke and TIA (II). Recommendations according to aetiological sub-type Guía para el tratamiento preventivo del ictus isquémico y AIT (II). Recomendaciones según subtipo etiológico168183, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=41813]], camposKey:0340-5354 2014-01-01 How predictors and patterns of stroke recurrence after a TIA differ during the first year of follow-up16141621, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=41805]], camposKey:2211-0348 2014-01-01 Immune reconstitution inflammatory syndrome and natalizumab-Is it possible before removing the drug?659661, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=69313]], camposKey:1015-9770 2014-01-01 LONG-TERM OUTCOMES IN ASYMPTOMATIC INTRACRANIAL ATHEROSCLEROSIS (The Barcelona-AsIA study)8788, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=41807]], camposKey:1759-8478 2014-01-01 Paraspinal arteriovenous malformation Onyx embolization via an Ascent balloon00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=41810]], camposKey:1015-9770 2014-01-01 Prestroke physical activity is associated with good functional outcome and arterial recanalization after stroke due to a large vessel occlusion304311, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=41808]], camposKey:0039-2499 2014-01-01 Relative cerebral blood volume as a marker of durable tissue-at-risk viability in hyperacute ischemic stroke113118, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=47404]], camposKey:0210-0010 2014-01-01 Resolución espontánea de una fístula dural arteriovenosa tipo IV190191, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=41812]], camposKey:1474-4422 2014-01-01 Safety and efficacy of uric acid in patients with acute stroke (URICO-ICTUS): A randomised, double-blind phase 2b/3 trial453460, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=41809]], camposKey:0271-678X 2014-01-01 Tract-specific fractional anisotropy predicts cognitive outcome in a community sample of middle-aged participants with white matter lesions861869, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=41817]], camposKey:0021-9150 2013-10-01 Asymptomatic cervicocerebral atherosclerosis, intracranial vascular resistance and cognition: The AsIA-Neuropsychology Study330335, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=41816]], camposKey:1015-9770 2013-10-01 Cognitive patterns in relation to biomarkers of cerebrovascular disease and vascular risk factors98105, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=69338]], camposKey:0140-6736 2013-08-10 Blood-pressure targets in patients with recent lacunar stroke: the SPS3 randomised trial507515, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=69334]], camposKey:0195-668X 2013-08-01 Detection of paroxysmal atrial fibrillation by an implantable subcutaneous holter in patients with non-lacunar cryptogenic ischemic stroke746746, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=41819]], camposKey:1351-5101 2013-07-01 Predictive value of brain and vascular imaging including intracranial vessels in transient ischaemic attack patients: External validation of the ABCD3-I score10881093, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=41820]], camposKey:0213-4853 2013-07-01 The costs of stroke in Spain by aetiology: The CONOCES study protocol Los costes del ictus en España según su etiología. El protocolo del estudio CONOCES332339, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=41822]], camposKey:0213-4853 2013-05-01 Clinical practice guidelines in intracerebral haemorrhage Guías de actuación clínica en la hemorragia intracerebral236249, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=41821]], camposKey:1351-5101 2013-05-01 Collateral circulation on perfusion-computed tomography-source images predicts the response to stroke intravenous thrombolysis795802, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=41823]], camposKey:1015-9770 2013-02-01 Decreased levels of angiogenic growth factors in intracranial atherosclerotic disease despite severity-related increase in endothelial progenitor cell counts8188, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=69332]], camposKey:1015-9770 2013-01-01 Barcelona-AsIA (Asymptomatic Intracranial Atherosclerosis) study: REGICOR, Intima-media thickness and ankle-arm index as predictors of asymptomatic cervicocerebral atherosclerosis163163, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=41825]], camposKey:0028-4793 2013-01-01 Bardoxolone methyl in type 2 diabetes and stage 4 chronic kidney disease24922503, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=69331]], camposKey:1015-9770 2013-01-01 Collateral circulation on Perfusion Computed Tomography Source Images correlates with hemodynamic abnormalities in PCT maps.185185, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=41818]], camposKey:0210-0010 2013-01-01 High performance of an implantable Holter monitor in the detection of concealed paroxysmal atrial fibrillation in patients with cryptogenic stroke and a suspected embolic mechanism Alto rendimiento del holter implantable en la detección de fibrilación auricular paroxística oculta en pacientes con ictus criptogénico y sospecha de mecanismo embólico251257, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=69333]], camposKey:1015-9770 2013-01-01 Optimisation of sample size calculation in thrombectomy trials using the natural history of proximal occlusions after i.v. thrombolysis failure1111, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=41824]], camposKey:0022-3050 2013-01-01 Recurrent transient ischaemic attack and early risk of stroke: Data from the PROMAPA study596603, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=41826]], camposKey:0210-0010 2012-12-12 Transcallosa diaschisis: Report of a case of crossed aphasia Diasquisis transcallosa: A propósito de un caso de afasia cruzada700701, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=69340]], camposKey:0210-0010 2012-12-01 Interhemispheric diaschisis: a case of crossed aphasia700701, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=41827]], camposKey:0213-4853 2012-11-01 Guidelines for the preventive treatment of ischaemic stroke and TIA (I). Update on risk factors and life style Guía para el tratamiento preventivo del ictus isquémico y AIT (I). Actuación sobre los factores de riesgo y estilo de vida560574, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=41828]], camposKey:0039-2499 2012-10-01 Biological signatures of asymptomatic extra- and intracranial atherosclerosis: The Barcelona-AsIA (Asymptomatic Intracranial Atherosclerosis) study27122719, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=41829]], camposKey:1355-6177 2012-09-01 Deep versus periventricular white matter lesions and cognitive function in a community sample of middle-aged participants874885, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=43299]], camposKey:1015-9770 2012-08-01 Perfusion computed tomography-guided intravenous thrombolysis for acute ischemic stroke beyond 4.5 hours: A case-control study3137, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=69341]], camposKey:0195-668X 2012-08-01 Subclinical atrial fibrillation: a missing link in the etiology of cryptogenic ischemic stroke?373373, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=41831]], camposKey:0149-5992 2012-06-01 Response to comment on: Calleja et al. Insulin resistance is associated with a poor response to intravenous thrombolysis in acute ischemic stroke. Diabetes Care 2011;34: 2413-241700, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=41832]], camposKey:0210-0010 2012-03-12 Perfusion computed tomography makes it possible to overcome important SITS-MOST exclusion criteria for the endovenous thrombolysis of cerebral infarction La tomografía computarizada de perfusión permite superar importantes criterios de exclusión SITS-MOST para la trombólisis endovenosa del infarto cerebral271276, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=69342]], camposKey:0210-0010 2012-03-01 Perfusion computed tomography makes it possible to overcome important SITS-MOST exclusion criteria for the endovenous thrombolysis of cerebral infarction271276, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=41833]], camposKey:0021-9150 2012-03-01 The Barcelona-Asymptomatic Intracranial Atherosclerosis (AsIA) study: Prevalence and risk factors221225, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=41834]], camposKey:1015-9770 2012-02-01 Prediction of early stroke recurrence in transient ischemic attack patients from the PROMAPA study: A comparison of prognostic risk scores182189, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=18361]], camposKey:0210-0010 2012-01-01 La tomografía computarizada de perfusión permite superar importantes criterios de exclusión SITS-MOST para la trombólisis endovenosa del infarto cerebral271276, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=41835]], camposKey:0197-4580 2012-01-01 Structural brain changes and cognition in relation to markers of vascular dysfunction00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=41837]], camposKey:0213-4853 2011-10-01 Health care resources for stroke patients in Spain, 2010: Analysis of a national survey by the Cerebrovascular Diseases Study Group Recursos asistenciales en ictus en España 2010: análisis de una encuesta nacional del Grupo de Estudio de Enfermedades Cerebrovasculares449454, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=41839]], camposKey:0021-9150 2011-09-01 Lipoprotein-associated phospholipase A 2 testing usefulness among patients with symptomatic intracranial atherosclerotic disease181187, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=41840]], camposKey:0213-4853 2011-09-01 Stroke health care plan (ICTUS II. 2010) Plan de asistencia sanitaria al ICTUS II. 2010383396, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=41838]], camposKey:0003-9942 2011-09-01 Stroke-related translational research11101123, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=8720]], camposKey:0039-2499 2011-03-01 Diffusion Tensor Imaging (DTI) Monitoring Of Motor Function Recovery After Middle Cerebral Artery Infarction: Searching For A DTI-Marker Of Neurorepair00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=69352]], camposKey:0039-2499 2011-03-01 Final Results Of The Barcelona-ASymptomatic Intracranial Atherosclerosis (ASIA) Study: Prevalence And Risk Factors00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=69349]], camposKey:0039-2499 2011-03-01 Prediction Of Very Early Stroke Or High-risk Stroke Mechanism In Patients With Transient Ischemic Attack From The Promapa Study. A Prospective Comparison Of Prognostic Risk Scores00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=69351]], camposKey:0039-2499 2011-03-01 Safety And Efficacy Of Intravenous Thrombolysis Beyond 4.5 Hours In Acute Ischemic Stroke Patients Selected By Perfusion Computed Tomography00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=69350]], camposKey:0039-2499 2011-03-01 Subclinical Extracranial Carotid And Peripheral Arterial Disease As Risk Factors For ASymptomatic Intracranial Atherosclerosis (ASIA) In The Barcelona-ASIA Study: The Relevance Of A Global Evaluation00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=41836]], camposKey:0149-5992 2011-01-01 Insulin resistance is associated with a poor response to intravenous thrombolysis in acute ischemic stroke24132417, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=41841]], camposKey:0039-2499 2011-01-01 Intracranial atherosclerosis: Current concepts00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=44872]], camposKey:1471-2377 2011-01-01 The population-based Barcelona-Asymptomatic Intracranial Atherosclerosis Study (ASIA): Rationale and design00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=41842]], camposKey:0213-4853 2010-10-01 Acute basilar artery thrombosis Trombosis aguda de la arteria basilar1823, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=41843]], camposKey:0028-3878 2010-08-31 Spot sign and live-imaged dramatic intracerebral hematoma expansion00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=69357]], camposKey:0039-2499 2010-04-01 Genotyping Recurrence Of Stroke (GRECOS) Project: Two Genes Involved in Hypoxia Responses and Blood Brain Barrier Function Are Associated With Vascular Recurrence in a Preliminary Study00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=69358]], camposKey:0039-2499 2010-04-01 Metabolic Syndrome is Associated With the Asymptomatic Phase of Intracranial Atherosclerosis00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=41844]], camposKey:0213-4853 2010-01-01 Vascular risk factors and cognitive performance in patients 50 to 65 years-old Factores de riesgo vascular y rendimiento cognitivo en personas de 50 a 65 años422429, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=41845]], camposKey:0210-5691 2009-11-01 Stroke units: The best treatment for stroke patients Unidades de ictus: el mejor tratamiento para los pacientes con ictus00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=41846]], camposKey:0213-4853 2009-10-19 Necessary components in the hospitals that attend patients with stroke: Results of a survey of Spanish experts Componentes necesarios en los hospitales que atienden a pacientes con ictus: Resultados de una encuesta de expertos españoles373378, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=69360]], camposKey:1424-7860 2009-08-22 Impact of previous knowledge of warning symptoms on extra-hospitalary latencies in patients with acute stroke00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=41847]], camposKey:0340-5354 2009-08-01 Influence of direct admission to Comprehensive Stroke Centers on the outcome of acute stroke patients treated with intravenous thrombolysis12701276, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=70958]], camposKey:0213-4853 2009-07-01 Necessary components in the hospitals that attend patients with stroke: results of a survey of Spanish experts373378, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=69362]], camposKey:0039-2499 2009-04-01 Influence Of Antiplatelet Pre-treatment On The Risk Of Intracranial Haemorrhage In Acute Ischemic Stroke After Intravenous Thrombolysis00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=41849]], camposKey:0039-2499 2009-04-01 Response to letter by tsivgoulis et al00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=69361]], camposKey:0039-2499 2009-04-01 The Population-based Asymptomatic Intracranial Atherosclerosis (BNM-ASIA) Study: Design And First Results.00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=41850]], camposKey:0039-2499 2009-02-01 The metabolic syndrome is associated with a higher resistance to intravenous thrombolysis for acute ischemic stroke in women than in men344349, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=41851]], camposKey:1015-9770 2009-01-01 C-reactive protein gene C1444T polymorphism and risk of recurrent ischemic events in patients with symptomatic intracranial atherostenoses95102, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=41848]], camposKey:0025-7753 2009-01-01 Prognostic impact of time-point and degree of arterial recanalization of acute middle cerebral artery occlusions after intravenous tPA administration Impacto pronóstico del tiempo y el grado de recanalización arterial tras trombólisis con activador tisular del plasminógeno en pacientes con oclusión aguda de la arteria cerebral media609615, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=41852]], camposKey:0028-3878 2008-07-15 Metabolic syndrome and resistance to IV thrombolysis in middle cerebral artery ischemic stroke190195, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=70950]], camposKey:0213-4853 2008-07-01 Training and experience in stroke units337341, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=69283]], camposKey:0025-7753 2008-06-28 Ateromatosis intracraneal141152, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=41854]], camposKey:0025-7753 2008-06-28 Intracranial atherosclerosis Ateromatosis intracraneal141152, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=41855]], camposKey:0039-2499 2008-05-01 Progression of symptomatic intracranial large artery atherosclerosis is associated with a proinflammatory state and impaired fibrinolysis14561463, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=41856]], camposKey:0039-2499 2008-04-01 Simvastatin reduces the association of NMDA receptors to lipid rafts: A cholesterol-mediated effect in neuroprotection12691275, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=69284]], camposKey:0039-2499 2008-02-01 Associated factors and prognostic implications of delay in acute stroke unit admission703703, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=69289]], camposKey:0039-2499 2008-02-01 C-reactive protein gene C1444T polymorphism is associated with an increased risk of further ischemic events in patients with symptomatic intracranial atherostenoses536536, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=69287]], camposKey:0039-2499 2008-02-01 Impact of the metabolic syndrome on the temporal profile of arterial recanalization after thrombolysis for acute middle cerebral artery ischemic stroke598598, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=69285]], camposKey:0039-2499 2008-02-01 Neuroprotection from stroke-induced excitotoxicity: Direct effect of statins on brain parenchyma mediated by inhibition of neuronal cholesterol synthesis678678, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=69286]], camposKey:0039-2499 2008-02-01 Nitric oxide mediates proliferation of endothelial progenitor cells in human ischemic stroke617617, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=69290]], camposKey:0039-2499 2008-02-01 The metabolic syndrome is associated with a higher resistance to i.v. thrombolysis for acute ischemic stroke in women than in men532532, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=69288]], camposKey:0039-2499 2008-02-01 Transcranial duplex 24 hour-monitoring of acute MCA occlusions after i.v. t-PA administration: Prognostic impact of time-point and degree of arterial recanalization592593, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=47399]], camposKey:0213-4853 2008-01-01 Aprendizaje y experiencia en las unidades de ictus337341, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=41859]], camposKey:0278-0240 2008-01-01 Biological signatures of brain damage associated with high serum ferritin levels in patients with acute ischemic stroke and thrombolytic treatment181188, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=41858]], camposKey:1351-5101 2008-01-01 Body temperature and response to thrombolytic therapy in acute ischaemic stroke13841389, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=41857]], camposKey:0028-3878 2008-01-01 Influence of the stroke code activation source on the outcome of acute ischemic stroke patients12381243, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=41860]], camposKey:0039-2499 2007-10-01 The increase of circulating endothelial progenitor cells after acute ischemic stroke is associated with good outcome27592764, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=41861]], camposKey:1015-9770 2007-08-01 Prognostic value of myocardial perfusion gated SPECT in patients with symptomatic intracranial large-artery atherosclerosis247254, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=41862]], camposKey:0039-2499 2007-07-01 The metabolic syndrome and stroke: Potential treatment approaches21962203, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=41863]], camposKey:0039-2499 2007-06-01 Serum cellular fibronectin and matrix metalloproteinase-9 as screening biomarkers for the prediction of parenchymal hematoma after thrombolytic therapy in acute ischemic stroke: A multicenter confirmatory study18551859, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=69293]], camposKey:0039-2499 2007-02-01 Endothelial progenitor cells mediate functional recovery in ischemic stroke518518, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=69294]], camposKey:0039-2499 2007-02-01 Metabolic syndrome and resistance to intravenous thrombolysis in stroke patients with acute middle cerebral artery occlusion499500, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=69291]], camposKey:0039-2499 2007-02-01 Molecular mechanisms of iron overload-related brain damage in patients with acute ischemic stroke and thrombolytic treatment568568, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=69295]], camposKey:0039-2499 2007-02-01 Plasma MMP-9 and fibronectin levels confirm their value as powerful predictors of hemorrhagic transformation after thrombolytic therapy in acute ischemic stroke: A multicenter prospective study463463, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=69292]], camposKey:0039-2499 2007-02-01 VEGF, SDF-1 alpha, and active MMP-9 mediate proliferation of endothelial progenitor cells in human ischemic stroke519519, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=41864]], camposKey:0001-6314 2007-01-01 C-reactive protein predicts further ischemic events in transient ischemic attack patients6066, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=41865]], camposKey:0039-2499 2007-01-01 Increased body iron stores are associated with poor outcome after thrombolytic treatment in acute stroke9095, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=69391]], camposKey:1471-2458 2007-01-01 Peripheral Arterial Disease Study (PERART): Prevalence and predictive values of asymptomatic peripheral arterial occlusive disease related to cardiovascular morbidity and mortality00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=43300]], camposKey:1092-8464 2007-01-01 The role of angiogenesis in damage and recovery from ischemic stroke205212, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=41866]], camposKey:0028-3878 2006-07-01 Plasma D-dimer predicts poor outcome after acute intracerebral hemorrhage9498, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=41867]], camposKey:0025-7753 2006-05-06 Usefulness of urgent combined carotid/transcranial ultrasound testing in early prognosis of TIA patients Efectividad del estudio ultrasonográfico precoz en el pronóstico a corto plazo de los pacientes con un accidente vascular cerebral isquémico transitorio647650, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=41868]], camposKey:1015-9770 2006-05-01 Gene expression in cerebral ischemia: A new approach for neuroprotection3037, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=41869]], camposKey:1351-5101 2006-04-01 Real-time monitoring of recanalization after intravenous thrombolysis for acute ischemic stroke [3]426427, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=70951]], camposKey:0213-4853 2006-03-01 Survey on the current situation of the young neurologists in Spain: analysis of their current working stability and degree of social protection6879, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=41870]], camposKey:0213-4853 2006-03-01 Survey on the current situation of the young neurologists in Spain: Analysis of their current working stability and degree of social protection Encuesta sobre la situación actual de los neurólogos jóvenes en España: Análisis de la estabilidad laboral y de la protectión social6879, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=69297]], camposKey:0039-2499 2006-02-01 Hemorrhagic transformation is associated with hyperthermia in patients with acute stroke626626, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=69296]], camposKey:0039-2499 2006-02-01 Influence of body temperature on the response to tissue plasminogen activator in acute ischemic stroke706706, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=41871]], camposKey:0039-2499 2006-02-01 Microbubble administration accelerates clot lysis during continuous 2-MHz ultrasound monitoring in stroke patients treated with intravenous tissue plasminogen activator425429, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=41872]], camposKey:1015-9770 2005-12-01 Basic mechanisms in intracranial large-artery atherosclerosis: Advances and challenges7583, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=41873]], camposKey:0039-2499 2005-08-01 Acute hyperglycemia state is associated with lower tPA-induced recanalization rates in stroke patients17051709, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=41874]], camposKey:0039-2499 2005-07-01 A matrix metalloproteinase protein array reveals a strong relation between MMP-9 and MMP-13 with diffusion-weighted image lesion increase in human stroke14151420, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=41875]], camposKey:0039-2499 2005-07-01 Predictors of early arterial reocclusion after tissue plasminogen activator-induced recanalization in acute ischemic stroke14521456, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=41876]], camposKey:0039-2499 2005-06-01 Silent myocardial ischemia in patients with symptomatic intracranial atherosclerosis: Associated factors12011206, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=41877]], camposKey:0039-2499 2005-03-01 Safety and efficacy of intravenous tissue plasminogen activator stroke treatment in the 3- to 6-hour window using multimodal transcranial Doppler/MRI selection protocol602606, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=69305]], camposKey:0039-2499 2005-02-01 A panel of biomarkers may successfully predict acute stroke diagnosis419419, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=69299]], camposKey:0039-2499 2005-02-01 C-reactive protein predicts progression of intracranial atherosclerotic stenoses498498, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=69300]], camposKey:0039-2499 2005-02-01 Differential response to thrombolysis among patients with tandem ICA/MCA occlusions449449, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=69301]], camposKey:0039-2499 2005-02-01 Geno-tPA: A pharmacogenomic approach to identifying polymorphisms modifying safety and efficacy of thrombolysis for acute stroke436437, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=69304]], camposKey:0039-2499 2005-02-01 Microbubbles administration accelerates clot lysis during continuous 2 MHz ultrasound monitoring in stroke patients treated with intravenous tPA419419, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=69302]], camposKey:0039-2499 2005-02-01 Safety and efficacy of intravenous tPA stroke treatment in the 3-to 6-hour window using a multimodal MRI selection protocol431432, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=69303]], camposKey:0039-2499 2005-02-01 Speed of diffusion-weighted imaging lesion expansion within 3 hours from stroke onset predicts evolution to malignant MCA infarction431431, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=41878]], camposKey:0039-2499 2005-01-01 Angiogenesis in symptomatic intracranial atherosclerosis: Predominance of the inhibitor endostatin is related to a greater extent and risk of recurrence9297, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=69322]], camposKey:0028-4793 2004-11-18 Ultrasound-enhanced systemic thrombolysis for acute ischemic stroke21702178, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=41879]], camposKey:0039-2499 2004-11-01 Impact of admission hyperglycemia on stroke outcome after thrombolysis: Risk stratification in relation to time to reperfusion24932498, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=41880]], camposKey:0039-2499 2004-09-01 Admission fibrinolytic profile is associated with symptomatic hemorrhagic transformation in stroke patients treated with tissue plasminogen activator21232127, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=41881]], camposKey:0033-8419 2004-08-01 Hyperacute ischemic stroke: Middle cerebral artery susceptibility sign at echo-planar gradient-echo MR imaging466473, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=41882]], camposKey:0028-3878 2004-07-13 High lipoprotein (a), diabetes, and the extent of symptomatic intracranial atherosclerosis2732, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=41883]], camposKey:0340-6245 2004-06-01 Admission fibrinolytic profile predicts clot lysis resistance in stroke patients treated with tissue plasminogen activator11461151, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=41884]], camposKey:0039-2499 2004-06-01 Temporal profile of matrix metalloproteinases and their inhibitors after spontaneous intracerebral hemorrhage: Relationship to clinical and radiological outcome13161322, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=70953]], camposKey:0025-7753 2004-04-17 Clinical benefit following the implementation of a specialized urgent stroke care system528531, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=69314]], camposKey:1567-5688 2004-04-01 Thrombotic risk factors and silent myocardial ischemia in patients with symptomatic intracranial large-artery atherosclerosis9393, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=69336]], camposKey:0210-0010 2004-03-16 Reversible segmental cerebral vasoconstriction: The value of duplex transcranial Doppler in its diagnosis and follow-up530533, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=41886]], camposKey:0210-0010 2004-03-16 Reversible segmental cerebral vasoconstriction: The value of duplex transcranial doppler in its diagnosis and follow-up Vasoconstricción segmentaria cerebral reversible: Utilidad del dúplex transcraneal en el diagnóstico y seguimiento530533, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=69339]], camposKey:0210-0010 2004-03-01 Clinical factors predicting the appearance of vascular events following a transient ischemic attack416421, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=41887]], camposKey:0210-0010 2004-03-01 Clinical factors predicting the appearance of vascular events following a transient ischemic attack Factores clínicos predictores de la aparición de episodios vasculares tras un ataque isquémico transitorio416421, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=41888]], camposKey:0039-2499 2004-02-01 Differential Pattern of Tissue Plasminogen Activator-Induced Proximal Middle Cerebral Artery Recanalization among Stroke Subtypes486490, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=69316]], camposKey:0039-2499 2004-01-01 Angiogenesis in symptomatic intracranial large-artery occlusive disease: Vascular endothelial growth factor and endostatin level are related to disease severity.317317, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=69317]], camposKey:0039-2499 2004-01-01 Baseline plasma PAI-1 level predicts recanalization, hemorrhagic transformation, and outcome in tPA-treated patients.292292, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=47415]], camposKey:0025-7753 2004-01-01 Beneficios clínicos de la implantación de un sistema de atención especializada y urgente del ictus528531, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=69335]], camposKey:0213-4853 2004-01-01 Homocysteine in the acute phase of stroke1014, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=41889]], camposKey:0213-4853 2004-01-01 Homocysteine in the acute phase of stroke Papel de la homocisteina en la fase hiperaguda del ictus1014, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=69318]], camposKey:0039-2499 2004-01-01 Impact of acute hyperglycemia on stroke outcome after thrombolysis: Risk stratification in relation to time to reperfusion251251, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=69319]], camposKey:0039-2499 2004-01-01 Predictors of early arterial reocclusion after tPA-induced recanalization250250, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=69315]], camposKey:0039-2499 2004-01-01 Proteolytic modifications on the metalloproteinase system (MMP-9-laminin-TIMP-1) induced by t-PA treatment for acute cerebral ischemia in humans339339, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=69320]], camposKey:0039-2499 2004-01-01 Speed of tPA-induced clot dissolution predicts the evolution of DWI abnormalities in hyperacute stroke236236, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=41891]], camposKey:0039-2499 2003-12-01 Safety Profile of Tissue Plasminogen Activator Treatment among Stroke Patients Carrying a Common Polymorphism (C-1562T) in the Promoter Region of the Matrix Metalloproteinase-9 Gene28512855, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=41892]], camposKey:0039-2499 2003-10-01 C-reactive protein predicts further ischemic events in first-ever transient ischemic attack or stroke patients with intracranial large-artery occlusive disease24632468, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=41893]], camposKey:0039-2499 2003-05-01 Effects of admission hyperglycemia on stroke outcome in reperfused tissue plasminogen activator-treated patients12351240, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=41894]], camposKey:0009-7322 2003-02-04 Matrix metalloproteinase-9 pretreatment level predicts intracranial hemorrhagic complications after thrombolysis in human stroke598603, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=70954]], camposKey:0025-7753 2003-01-25 Stroke code impact on the efficacy of thrombolytic treatment4751, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=69344]], camposKey:0039-2499 2003-01-01 Diurnal variation on recanalization rates after intravenous tPA for acute stroke: A multicenter study279280, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=47414]], camposKey:0025-7753 2003-01-01 Impacto de la activación del Código Ictus en la eficacia del tratamiento trombolítico4751, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=69343]], camposKey:0039-2499 2003-01-01 Intravenous tPA for ischemic stroke in the elderly: Safety and efficacy in routine clinical practice311311, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=69345]], camposKey:0039-2499 2003-01-01 Matrix metalloproieinase (MMP-9) is related to glucose level and predicts cerebral infarct size on DWI and bleedings in tPA-treated patients278278, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=41896]], camposKey:0271-678X 2003-01-01 Plasmatic Level of Neuroinflammatory Markers Predict the Extent of Diffusion-Weighted Image Lesions in Hyperacute Stroke14031407, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=69347]], camposKey:0039-2499 2003-01-01 Serum glucose as a predictor of poor outcome in reperfused tPA treated patients270270, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=69346]], camposKey:0039-2499 2003-01-01 Serum lipoprotein (A) is a powerful marker of the extent and severity of MRA-confirmed intracranial atherosclerotic large-vessel disease270270, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=69348]], camposKey:0039-2499 2003-01-01 Thrombin-activable fibrinolysis inhibitor (TAFI) level is related to T-PA-induced recanalization resistance after human ischemic stroke240240, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=70955]], camposKey:0025-7753 2002-12-07 Hematomyelia as late side effect of radiation799799, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=41897]], camposKey:0025-7753 2002-12-07 Hematomyelia as late side effect of radiation [6] Hematomielia espontánea como efecto tardío de la radioterapia00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=69356]], camposKey:0210-0010 2002-11-01 Study of the hypoplasic internal carotid artery by use of multislice spiral computed tomography two case reports832837, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=41898]], camposKey:0210-0010 2002-11-01 Study of the hypoplasic internal carotid artery by use of multislice spiral computed tomography. Two case reports Estudio de la arteria carótida interna hipoplásica mediante tomografía computarizada helicoidal multicorte. A propósito de dos casos832837, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=41899]], camposKey:0039-2499 2002-09-01 Prediction of early neurological deterioration using diffusion- and perfusion-weighted imaging in hyperacute middle cerebral artery ischemic stroke21972203, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=41900]], camposKey:0213-4853 2002-08-15 Chronic subdural hematoma simulating a TIA. Implications for the management transient neurological deficit Hematoma subdural crónico simulando un AIT. Implicaciones en el tratamiento del déficit neurológico transitorio342344, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=41901]], camposKey:0039-2499 2002-06-22 Thrombolysis-related hemorrhagic infarction: A marker of early reperfusion, reduced infarct size, and improved outcome in patients with proximal middle cerebral artery occlusion15511556, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=70956]], camposKey:0213-4853 2002-06-01 Chronic subdural hematoma simulating a TIA. Implications for the management transient neurological deficit342344, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=69367]], camposKey:0039-2499 2002-01-01 Circadian variations on successful recanalization after thrombolysis in acute cardioembolic stroke371371, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=69368]], camposKey:0039-2499 2002-01-01 Expansion of the hyperacute (< 6h) diffusion defect within the ischemic penumbra is an independent predictor of stroke outcome. A multivariate analysis362363, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=69366]], camposKey:0039-2499 2002-01-01 Reperfusion injury after human cardioembolic stroke? A possible role for inflammatory mechanisms405405, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=69369]], camposKey:0039-2499 2002-01-01 Thrombolysis-related hemorrhagic infarction (HI1 and HI2). A marker of reperfusion, reduced infarct size and improved outcome in patients with proximal MCA occlusion352353, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=69364]], camposKey:0210-0010 2001-07-16 Correlation between the expression of proinflammatory cytokines and matrix metalloproteinases in the acute phase of an ischemic stroke115118, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=70959]], camposKey:0025-7753 2001-01-20 Acute phase response after stroke: differences between ischemic stroke and intracerebral hemorrhage5455, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=41903]], camposKey:0025-7753 2001-01-20 Acute phase response after stroke: Differences between ischemic stroke and intracerebral hemorrhage Reactantes de fase aguda en el ictus: Diferencias entre el infarto isquémico y la hemorragia intracerebral5455, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=69365]], camposKey:0039-2499 2001-01-01 Adhesion molecule (ICAM-1) serum levels are related to spontaneous recanalization in human ischemic stroke.340340, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=41902]], camposKey:0210-0010 2001-01-01 Correlation between the expression of proinflammatory cytokines and matrix metalloproteinases in the acute phase of an ischemic stroke Correlación entre la expresión de citocinas proinflamatorias y metaloproteinasas de matriz en la fase aguda del ictus isquémico115118, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=41908]], camposKey:0039-2499 2001-01-01 Matrix metalloproteinase expression after human cardioembolic stroke: Temporal profile and relation to neurological impairment17591766, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=41905]], camposKey:0039-2499 2001-01-01 Matrix metalloproteinase expression is related to hemorrhagic transformation after cardioembolic stroke27622767, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=41904]], camposKey:0039-2499 2001-01-01 Progression and clinical recurrence of symptomatic middle cerebral artery stenosis: A long-term follow-up transcranial Doppler ultrasound study28982904, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=81436]], camposKey:0025-7753 2001-01-01 Reactantes de fase aguda en el ictus: diferencias entre el infarto isquémico y la hemorragia intracerebral5455, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=41907]], camposKey:0039-2499 2001-01-01 Time course of tissue plasminogen activator-induced recanalization in acute cardioembolic stroke: A case-control study28212827, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=41906]], camposKey:0039-2499 2001-01-01 Timing of spontaneous recanalization and risk of hemorrhagic transformation in acute cardioembolic stroke10791084, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=41909]], camposKey:0213-4853 2000-12-01 High level of protein content in LCR and borderline values of intracranial pressure in a patient with benign sexual headache Hiperproteinorraquia y valores límite de presión intracraneal en un paciente con cefalea sexual benigna317318, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=70957]], camposKey:0025-7753 2000-01-15 Acute bilateral ophthalmoplegia with raised anti-GQ1b antibodies3838, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=41910]], camposKey:0025-7753 2000-01-01 Acute bilateral ophthalmoplegia with raised anti-GQ1b antibodies Oftalmoplejía bilateral aguda con elevación de anticuerpos anti-GQ1b.00][CapitolsLlib{id=com.sigma.fs3.argos.domain.gpc.GpcCapitolsLlibPK[ifcactivitat=CAP, ifccomptador=32753]},camposKey: Evidence-Based Practice and Trends in Visual Rehabilitation for Patients with Age-Related Macular Degeneration 978-1-83968-903-1Recent Advances and New Perspectives in Managing Macular Degeneration 1 2022-01-01 IntechOpen, CapitolsLlib{id=com.sigma.fs3.argos.domain.gpc.GpcCapitolsLlibPK[ifcactivitat=CAP, ifccomptador=32310]},camposKey: 433 454 Educational opportunities of virtual game-based initiatives for students with disabilities 1668442876Handbook of Research on the Influence and Effectiveness of Gamification in Education 1 2021-11-30 -, CapitolsLlib{id=com.sigma.fs3.argos.domain.gpc.GpcCapitolsLlibPK[ifcactivitat=CAP, ifccomptador=15768]},camposKey: 113 124 Natural Course and Prognosis 978-140517822-8Intracranial Atherosclerosis 1 2009-01-01 ][][Llibres{id=com.sigma.fs3.argos.domain.gpc.GpcLlibresPK[ifcactivitat=LLI, ifccomptador=123464],camposKey=978-84-9110-476-6Neurosonología 1 2011-01-01 Editorial Médica Panamericana}][][][][com.sigma.fs3.argos.domain.gpc.GpcAltresAjutsBeca[id=com.sigma.fs3.argos.domain.gpc.GpcAltresAjutsBecaPK[ifcactivitat=AAB, ifccomptador=64236]], com.sigma.fs3.argos.domain.gpc.GpcAltresAjutsBeca[id=com.sigma.fs3.argos.domain.gpc.GpcAltresAjutsBecaPK[ifcactivitat=AAB, ifccomptador=62216]], com.sigma.fs3.argos.domain.gpc.GpcAltresAjutsBeca[id=com.sigma.fs3.argos.domain.gpc.GpcAltresAjutsBecaPK[ifcactivitat=AAB, ifccomptador=63943]]][com.sigma.fs3.argos.domain.gpc.GpcAltresAjutsBeca[id=com.sigma.fs3.argos.domain.gpc.GpcAltresAjutsBecaPK[ifcactivitat=AAB, ifccomptador=64236]], com.sigma.fs3.argos.domain.gpc.GpcAltresAjutsBeca[id=com.sigma.fs3.argos.domain.gpc.GpcAltresAjutsBecaPK[ifcactivitat=AAB, ifccomptador=62216]], com.sigma.fs3.argos.domain.gpc.GpcAltresAjutsBeca[id=com.sigma.fs3.argos.domain.gpc.GpcAltresAjutsBecaPK[ifcactivitat=AAB, ifccomptador=63943]]][][][com.sigma.fs3.argos.domain.gpc.GpcTesis[id=com.sigma.fs3.argos.domain.gpc.GpcTesisPK[ifcactivitat=TES, ifccomptador=31012]], com.sigma.fs3.argos.domain.gpc.GpcTesis[id=com.sigma.fs3.argos.domain.gpc.GpcTesisPK[ifcactivitat=TES, ifccomptador=30735]], com.sigma.fs3.argos.domain.gpc.GpcTesis[id=com.sigma.fs3.argos.domain.gpc.GpcTesisPK[ifcactivitat=TES, ifccomptador=30557]], com.sigma.fs3.argos.domain.gpc.GpcTesis[id=com.sigma.fs3.argos.domain.gpc.GpcTesisPK[ifcactivitat=TES, ifccomptador=30449]], com.sigma.fs3.argos.domain.gpc.GpcTesis[id=com.sigma.fs3.argos.domain.gpc.GpcTesisPK[ifcactivitat=TES, ifccomptador=2145636189]], com.sigma.fs3.argos.domain.gpc.GpcTesis[id=com.sigma.fs3.argos.domain.gpc.GpcTesisPK[ifcactivitat=TES, ifccomptador=2145638667]], com.sigma.fs3.argos.domain.gpc.GpcTesis[id=com.sigma.fs3.argos.domain.gpc.GpcTesisPK[ifcactivitat=TES, ifccomptador=2145632712]]][][][][][][][][][][com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@5f94f0, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@5f8c9c, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@5f9570, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@5f8848, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@5f96ec, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@5f82ab, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@5f93bf, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@5f93c0, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@5f97d1, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@5f82a6, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@5f8b5f, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@5f88eb, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@5f82a4, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@5f8b0b, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@5f9061, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@5f97e1, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@5f81c9, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@5f82aa, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@5f9118, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@375207, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@375258, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@37d76c, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@5f89b7, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@5f88e6, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@5f89d6, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@5f8bf9, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@5f8829, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@5f8758, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@5f8607, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@5f984c, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@5f8c67, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@5f985e, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@5f8d24, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@5f92df, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@5f932f, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@5f94a2, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@5f94ca, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@5f8331, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@5f9044, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@5f87cd, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@5f988a, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@5f8507][][][][][][][][com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@5bc684], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@467c1d], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@56fa90], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@467bdf], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@414ec1], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@467c1b], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@4125a2], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@4123f4]][][][][][][com.sigma.fs3.argos.domain.gpc.altres.ProjecteInnovacio@14bca][]
